XML 68 R59.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share-based Compensation - Stock Option Activity Under 2023 Incentive Award Plan (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Options, Weighted Average Exercise Price          
Share-based compensation expense $ 1.7 $ 1.1 $ 3.3 $ 2.5  
AEON Biopharma Inc 2023 Incentive Award Plan | Stock options          
Options, Number of Shares          
Outstanding, beginning of period     331,753    
Options granted     698,360    
Options forfeited     (88,229)    
Outstanding, end of period 941,884   941,884   331,753
Options, Weighted Average Exercise Price          
Outstanding, beginning of period     $ 5.47    
Options granted     13.26    
Outstanding, end of period $ 10.75   10.75   $ 5.47
Weighted average fair value of options granted per share     $ 6.89   $ 3.18
Weighted average remaining contractual life of options exercisable     9 years 6 months   9 years 7 months 6 days
Share-based compensation expense $ 0.4   $ 0.5    
Unrecognized compensation expense related to non-vested stock options $ 5.2   $ 5.2   $ 0.9
Weighted-average remaining requisite service period for which unrecognized compensation expense     38 months   35 months